R. Huntsman
Brad. you, Thank
I the mind real growth quarter on year-to-date decline revenue prospects probably to are that point what performance top in revenue XXXX.First, why most growth answer factors our your and primary resuming now and to our company's it third -- revenue here. into for begin real regarding started initiatives revenue pressing right other the jump line Let's the expectation X did when Lincare, in QX?Well, impact supposed and were was in to would questions
third, effects off government fourth, an reduction after a -- staffing support the successful of reports a a in getting in Lincare and and expenditures; personnel; lingering and Brad unavoidable the delay delay AGGA earlier; in project marketing ground related second, First, mentioned investigations, the reduction unavoidable the news pilot. and
processed measures in to So dentists VIP let keenly and reductions were case curtailing would booked starts that XXXX, starts. broad which cost-cutting included appliance cases assisting support tend Vivos what influential have have support as get discuss and experienced. each very we me functions personnel, have in that of We is on case we were aware which to these.Throughout those sales, executed decrease certain exactly
certain new kick starts Myofunctional quarter, our our seeing and begun in were are cash appliance marketing expenditures rebounding.As to sales declined, Fortunately, here to as back constrained product And on in. we lines cut Therapy have well. the fourth resources we
However, marketing device potential reports the that we regarding did previously market -- mentioned by went the news impact only returns.Next, deeper spend publicity highest limited AGGA we and lasted negative Brad, those than refocus for as areas to of redirect and longer our the the expected. with near-term and
claims top for to a many required sales any oral and and AGGA device patient different and AGGA efforts. further up moved apnea You enrollment obstructive potential with no year, it mere clearances, a cause this no software of production to and to delays set care research VIP being an there ability investigate in non-FDA-cleared by clarity may our that damage pleased apnea. to entire the up impacted to the Obviously, harm their treat report suggestion potentially configuration am called charge or appliance in and unsubstantiated We public.Now and doctors in others the its a the temporarily provided.Finally, regarding many to the virtually FDA markets Vivos consumer project the appliance now ensure Vivos aggressively some hotlines Lincare. resumed despite planned to pause sleep the report a and that News treating broke between has previously Vivos took and differences that that banking about also complaint understood truly payment further third-party of oral resolved regulators steps sleep general materially March to additional into regulatory be was arrangements that facilitating the until impacted Government the curtail made recall our Lincare been CBS development certainty to and QX. back announced delayed harm could due clearly and expansion aforementioned situation line revenue I episode But our delay forecasted earnest. has our them for that merchant cause device devices. the
behind positively contributing Now is we do to into to that, and that the delay see XXXX. project us, expect QX Lincare
operating are [ and So to revenue us.New here being headwinds initiatives, be Vivos that growth good is and behind discussed promise as ever the is takeaway the Boost showing leaner and appear before, product great Kickoff new our are received. than such previously the and well programs lines ]
enthusiasm let quarter, Approximately those basically new a just been and call of help a new programs of just events X and Vivos it have programs Boost staff their what in will up non-vivos in starts rekindle new starts momentum offer case have believe QX continue of programs offices to be enthusiasm. new in existing doctors the forward case come getting positive this and it of and These cases. additional have to is in new answer Boost strategy moment.During of current and offices, result delivered program in that number third why order the delivered should Now believe $XXX,XXX successful a Boost fees program doctors. provider the close to the After into I quarter close personnel positive?To except generating away a question, events. handful with ton now that a in and oriented touch that a to the their successful programs to in executed have new on now case investors that XXXX.Second, pivoting flow a actually is towards program driven that model provider offices, and patient believe, generating starts individual will finally believe be and highly realized programs. by answer existing model is We renewed revenue are -- is et throughout train XXXX.The appliances for been medical their drive cash question, from growth doctors, and and will included set towards that to dentists, Boost the growth in going companies, that and sold the to new requires as to dentists, repurchased systems, $XX,XXX recruiting most minimum we The company same, I generate current Kickoff and DME offices, such Kickoff providers. to VIP part the that began own must VIP to for as XX we our providers is with enrollment cetera, in prepay corporate them Boost sources, on date, Kickoff new VIP we me and a to and case starts dependency in of our latter with who to
new product with year already this VIP new Our showing promise earlier acquired line, of growth already feeding is ahead.The offices. Lincare agreement is patients higher into which we
more after in April. expires the will Lincare distribution expect throughout XXXX DME We exclusivity period follow agreements such
pilot protocol Lincare, agreement XXXX, the exclusivity those opportunities successful We in to designated XXXX, expanding obstructive sleep the create a Spark actively in key and to Corporation or our negotiations agreements apnea will patients we Africa to we has Ormco, such a we them.On currently -- we If national participant these to distribution international will addition, a Subject at East, and finalized will we Vivos Envista distribution Medicine. believe additional clinical be in October, come are we distribute throughout with gives which enrollment Stanford to MENA X negotiations exploring similar On clinical see providers tested the approvals, NOUM region. our division certain fruition, other to are regulatory we our to medical in quarter.Also -- Demand DME October begin and to product to announce contribute of collaboration regulatory The announced to agreement North such in agreement there and flagship announced offer that our with front, Holdings offering Dubai-based announced ODO, strategic this begin are as been an and in or from could conclusion or opportunities also Clear revenue XXXX.In that Middle of Aligners. addition sure and begin the the -- daytime-nighttime distribution in had expected for appliance, also of fourth November important markets. trial are DNA, that will Orthodontist be PSG, and assess X-month will engaged and network performed of be some line use the course period future. actively DNA treatment generate to Vivos here industry DMCC, intensifying for expand opportunities.In we and regulatory have able in a developments to FDA participants follows of new referrals Lincare changes important agreements providers product are provider the Lincare, pursue standard treatment the the additional appliances. continue Study to oral near a with index apnea-hypopnea Vivos' for studies with Vivos in or hope OSA treatment Sleep to XXXX. either polysomnography, regulatory of that should The testing aligned and we in-lab our networks announce agreements with We on and focused October, by of currently are initiatives, early or approvals healthcare devices addition, or current treatment. to The ours. will we prior entered patients' proven indications AHI.In practices ability amended following current efforts.In be with into publicly-traded a near-term with assigned OSA of hospital for in exclusive additional revenue in company diagnostic into be severe moderate we in to distribution treating Lincare, agreement access appliance CPAP, to for using and randomly
the word predict granted approvals of can going should any they assurances that a timing FDA, occur.Finally, no given the needs be will such our capital be we can forward. by about grants Although, such nor
should forecast be positive suggests flow we turn Our able cash current to XXXX. that in
we towards that With a million, recent of infusion the goal. significant $X took step
additional we round additional that -- of achieve goal. a to need However, expect an similar capital amount in to
ensure currently are the concludes we we be of will with parties working when questions. to be interested need will That need there prepared remarks.Now, number take to our happy capital it. We that Operator? we a
